Kennedy researchers have uncovered key design parameters for bispecific T-cell engagers (TcEs)—a class of cancer immunotherapy drugs. The findings may help unlock the full potential of TcEs and ...

In this GEN panel discussion, three experts in cell and gene therapy development will share lessons and strategies learned ...

Generally, fighting cancer is about delivering a relentless attack on the spreading disease, but a new approach explores the ...

The toxic fungus Aspergillus flavus— known as the “Pharaoh’s Curse” due to its role in the deaths of archaeologists who ...

One of the largest barriers is developing reliable potency assays for these cell-based medicines, which by nature are highly heterogeneous. An engineered lot will inevitably have a distribution of ...

Artificial nanostructured surfaces mimicking natural cell environments enhance CAR T-cell activation, longevity, and potency by promoting the generation of central memory T cells.

During the oral presentation “Cell Mimics As High Precision Controls for CGT Analytics and Potency Assays” Robyn Hall, Ph.D., Cell Therapy Specialist at Slingshot Biosciences, will highlight ...

Cell Potency Screening Might Be Needed. In the feasibility trial, mononuclear cells from bone marrow aspirate that has high numbers of specific cell types, such as CD34+ positive cells, produced ...

Researchers led by John T. Wilson, Vanderbilt University associate professor of chemical and biomolecular engineering and ...

In the ever-evolving cell therapy landscape, the challenge of potency assay development remains critical. At the 4th Cell Therapy Potency Assay Summit, we will unite analytical development ...

Slingshot Biosciences, the leader in precision-engineered cell mimic technologies, today announced the launch of TruCytes™ Potency, a new class of biomarker cell mimics specifically designed for ...